WO2023052970 - PYRROLOBENZODIAZEPINE CONJUGATES FOR CANCER TREATMENT
National phase entry:
Publication Number
WO/2023/052970
Publication Date
06.04.2023
International Application No.
PCT/IB2022/059148
International Filing Date
27.09.2022
Title **
[English]
PYRROLOBENZODIAZEPINE CONJUGATES FOR CANCER TREATMENT
[French]
CONJUGUÉS DE PYRROLOBENZODIAZÉPINE POUR LE TRAITEMENT DU CANCER
Applicants **
SONY GROUP CORPORATION
1-7-1 Konan, Minato-ku
Tokyo 108-0075, JP
Inventors
MATRAY, Tracy
1730 N. First St.
San Jose, California 95112, US
Priority Data
63/250,931
30.09.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 3993 | |
| EPO | Filing, Examination | 41364 | |
| Japan | Filing | 594 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 15610 |
Total: 62136 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
, q, w, m and n are as defined herein. Compounds of structure (I) find utility in a number of applications, including use as therapeutic agents for various treatment methods.[French]
, q, w, m et n étant tels que définis dans la description. Les composés de structure (I) trouvent une utilité dans un certain nombre d'applications, y compris leur utilisation en tant qu'agents thérapeutiques pour divers procédés de traitement.